neurology-2018-posters-abstracts

t h

E u r o S c i C o n C o n f e r e n c e o n

Neurology & Neurological

Disorders

Neurology 2018

J u l y 1 2 - 1 3 , 2 0 1 8

P a r i s , F r a n c e

Page 92

Journal of Neurology and Neuroscience

ISSN: 2171-6625

he OxQUIP (Oxford QUantification in Parkinsonism) study has been recruiting patients with Parkinson's disease and

progressive supranuclear palsy. Currently available treatments for these diseases are symptomatic only, and do not have any

preventive or disease-slowing effect. As new drugs are developed, we need to be able to evaluate them quickly, so that precious

time and resources can be devoted to those showing most promise. In this study, we follow participants intensively over a two

year period, with the aim of identifying measures that can detect disease progression over much shorter time periods than is

possible at present. During the study, participants are asked to perform simple tasks while we measure movements of the eyes,

hands and body. We also do some tasks on a tablet computer that measure cognitive performance. Today, I will present you some

of the recent exciting data from the OxQUIP study.

Oxford study in quantification of Parkinsonism

(OxQUIP) - eye movements, gait tracking and

cognitive function

Chrystalina Antoniades

University of Oxford, Oxford, UK

J Neurol Neurosci 2018, Volume: 9

DOI: 10.21767/2171-6625-C1-009